Terns Pharmaceuticals (TERN) Interest & Investment Income (2020 - 2022)
Historic Interest & Investment Income for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $1.3 million.
- Terns Pharmaceuticals' Interest & Investment Income rose 231454.55% to $1.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.1 million, marking a year-over-year increase of 114117.65%. This contributed to the annual value of $13.3 million for FY2024, which is 300.75% up from last year.
- Per Terns Pharmaceuticals' latest filing, its Interest & Investment Income stood at $1.3 million for Q4 2022, which was up 231454.55% from $499000.0 recorded in Q3 2022.
- Over the past 5 years, Terns Pharmaceuticals' Interest & Investment Income peaked at $1.3 million during Q4 2022, and registered a low of $1000.0 during Q3 2020.
- Moreover, its 3-year median value for Interest & Investment Income was $52500.0 (2020), whereas its average is $194583.3.
- Within the past 5 years, the most significant YoY rise in Terns Pharmaceuticals' Interest & Investment Income was 480000.0% (2021), while the steepest drop was 7800.0% (2021).
- Over the past 3 years, Terns Pharmaceuticals' Interest & Investment Income (Quarter) stood at $2000.0 in 2020, then surged by 2650.0% to $55000.0 in 2021, then skyrocketed by 2314.55% to $1.3 million in 2022.
- Its last three reported values are $1.3 million in Q4 2022, $499000.0 for Q3 2022, and $214000.0 during Q2 2022.